International Stem Cell Corp. (ISCO) Looking to Transform Parkinson’s Disease Treatment with ISC-hpNSC™ Clinical Trial
Last month, International Stem Cell Corp. (OTCQB: ISCO) published the results of its 12-month pre-clinical, non-human primate study demonstrating the…